Keyphrases
Phencyclidine
100%
Subchronic
70%
Novel Object Recognition
70%
Schizophrenia
60%
Atypical Antipsychotics
52%
Efflux
52%
Acetylcholine
51%
Dopamine
41%
Mouse Model
38%
Rodents
38%
Cognitive Impairment
37%
Lurasidone
37%
Schizophrenia Models
30%
Memory Deficits
29%
5-HT1A
28%
Reversal Learning
28%
Negative Symptoms
25%
Glutamate
24%
Agonism
24%
Antagonism
24%
Medial Prefrontal Cortex (mPFC)
24%
Social Interaction
23%
Cognitive Deficits
23%
Receptor Antagonism
20%
Blonanserin
19%
Dopamine D1 Receptor
19%
Humanized
19%
Negative Symptoms of Schizophrenia
19%
Knock-in Mouse Model
19%
Neurotransmitters
18%
Serotonin 2A Receptor (5-HT2AR)
18%
5-HT7
18%
Declarative Memory
17%
Episodic Memory
16%
N-methyl-D-aspartate Receptor (NMDAR)
16%
Tandospirone
16%
Dopamine Efflux
14%
Learning Impairment
14%
Receptor Antagonist
14%
Positive Allosteric Modulator
13%
Partial Agonism
13%
Locomotor Activity
13%
Cognitive Impairment Associated with Schizophrenia
12%
Dorsal Striatum
12%
Olanzapine
12%
Executive Function
11%
Neurosteroids
11%
Pregnenolone Sulfate
11%
Psychosis
11%
Glutamate Efflux
11%
Pharmacology, Toxicology and Pharmaceutical Science
Phencyclidine
99%
Effusion
65%
Cognitive Defect
65%
Acetylcholine
61%
Atypical Antipsychotics
61%
Receptor
43%
Lurasidone
40%
Serotonin
37%
Glutamic Acid
35%
Negative Syndrome
33%
Mouse Model
29%
4 Aminobutyric Acid
26%
Neurotransmitter
19%
Dopamine 1 Receptor
19%
Blonanserin
19%
Learning Disorder
18%
Tandospirone
18%
Noradrenalin
17%
Receptor Antagonist
17%
Olanzapine
17%
Dextro Aspartic Acid
16%
Positive Allosteric Modulator
15%
Partial Agonist
15%
Antipsychotic
12%
Pregnenolone Sulfate
12%
Neurosteroid
12%
Dopamine 3 Receptor
9%
Positive Syndrome
9%
N Methyl Dextro Aspartic Acid Receptor
9%
4 Aminobutyric Acid A Receptor Stimulating Agent
9%
Rapastinel
9%
Pimavanserin
9%
Tardive Dyskinesia
9%
Vesicular Monoamine Transporter 2
9%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
8%
Inverse Agonist
7%
Ketamine
7%
2 (6 Chloro 5 Fluoro 1 Indolyl) 1 Methylethylamine
6%
Amphetamine
6%
NMDA Receptor Antagonist
5%
Hyperactivity
5%
3 [2 [2 (4 Methyl 1 Piperidinyl)ethyl] 1 Pyrrolidinesulfonyl]phenol
5%
N Methyl Dextro Aspartic Acid Receptor Blocking Agent
5%
Microdialysis
5%
Dizocilpine
5%
Typical Antipsychotic
5%
U-Shaped Dose Response
5%
Parkinson's Disease
5%
Desensitization
5%
Neuroscience
Phencyclidine
81%
Cognitive Disorders
74%
Acetylcholine
52%
Atypical Antipsychotic
45%
Lurasidone
40%
Glutamic Acid
35%
Gamma-Aminobutyric Acid
34%
Serotonin
32%
Agonist
27%
Antipsychotic
27%
Prefrontal Cortex
27%
Receptor
26%
Social Interaction
24%
Negative Syndrome
23%
Declarative Memory
19%
Dopamine Receptor D1
19%
Partial Agonism
19%
Tandospirone
19%
Episodic Memory
18%
Neurotransmitter
17%
Receptor Antagonist
17%
Dextro Aspartic Acid
17%
Learning Disabilities
17%
Positive Allosteric Modulator
16%
Norepinephrine
13%
Recognition Memory
12%
Dorsal Striatum
12%
Locomotor Activity
12%
Neurosteroid
12%
Pregnenolone Sulfate
12%
Cognitive Function
10%
NMDA Receptor Antagonist
10%
Olanzapine
9%
Pimavanserin
9%
Receptor Agonists
9%
5-HT7 Receptor
9%
Tardive Dyskinesia
9%
NMDA Receptor
9%
Vesicular Monoamine Transporter 2
9%
GABAA Receptor
9%
Haloperidol
8%
Inverse Agonist
7%
Microdialysis
6%
Executive Function
6%
Social Behavior
5%
Hippocampus
5%
Hyperactivity
5%
Parkinson's Disease
5%
5-HT2A Receptor
5%
Dopamine Receptor D2
5%